MGEN - miRagen Therapeutics' (MGEN) CEO Bill Marshall on Q2 2019 Results - Earnings Call Transcript
miRagen Therapeutics, Inc. (MGEN)
Q2 2019 Earnings Conference Call
August 7, 2019 4:30 PM ET
Company Participants
Dan Ferry – Managing Director-LifeSci Advisors, LLC
Bill Marshall – President and Chief Executive Officer
Jason Leverone – Chief Financial Officer
Conference Call Participants
Liana Moussatos – Wedbush Securities
Jonathan Miller – Evercore ISI
Jennifer Grayson – R. W. Baird
Leland Gershell – Oppenheimer
Suji Jeong – Jefferies
Presentation
Operator
Greetings and welcome to the miRagen Therapeutics’ Q2 2019 Earnings Conference Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the